BRCA 1/2 mutations can increase the risk of developing cancer at an earlier age. By identifying these mutations, clinicians can implement more frequent and targeted screenings, allowing for potentially improved treatment outcomes.

This gene panel provides valuable insights into the tumor’s genetic makeup, enabling personalized treatment approaches. Certain targeted therapies and medications have shown exceptional efficacy in patients with BRCA 1/2 mutations, leading to better treatment response and potentially improved survival rates.

BRCA 1/2 mutations are hereditary, meaning they can be passed down from generation to generation. Identifying mutations in these genes makes it possible to determine if other family members are also at risk. This knowledge empowers people to undergo genetic testing and make informed decisions about their health.

Knowledge of BRCA 1/2 status allows for proactive preventive measures. For high-risk individuals, preventive surgeries, such as prophylactic mastectomy or oophorectomy, can significantly reduce the chances of developing cancer.

Our Cancer Gene Panel thoroughly assesses clinically relevant genes, ensuring accurate and reliable results.

We utilize cutting-edge next generation sequencing technology to deliver precise and detailed genetic information.

Our team of experienced genetic counselors and healthcare professionals will guide you through the testing process, answer your questions, and help you understand the implications of the results.

We adhere to strict privacy protocols and maintain the confidentiality of your genetic information.